A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Two ducklings trapped in a sewer were rescued when quick-thinking workers coaxed them back using an iPad recording of their mother's quack.
Gregory Maxwell and Brian Atkins joked they were taking their Australian victim on a 'bush tucker trial' before dumping him beside a road.
A sister who donated her late brother's face to a man who suffered a life-threatening, disfiguring injury has met him for the first time.